Guggenheim Securities · 2 hours ago
Experienced Associate - Equity Research, BioTech
Boston, MA
Full-time
Onsite
Entry, Mid Level
$140K/yr - $165K/yr
1+ years expGuggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. They are seeking an exceptional candidate to join as a sell-side Equity Research Associate to help cover the Biotechnology sector, focusing on analyzing companies and making stock recommendations to institutional investor clients.
Financial Services
Responsibilities
Provide support to the Senior Analyst through fundamental analysis and investment research in equity markets with an emphasis on original, bottom-up research in the Biotechnology sector
Analyze individual Biotechnology companies to build and update fully integrated financial and valuation models
Write comprehensive research reports and present findings; draft reports/notes on relevant investment themes, events and breaking news
Conduct primary research through industry sources including, but not limited to, financial analysis, due diligence clinical data and industry trends, company management and strategies
Organize physician calls for investors and investor events
Update analyst marketing handout regularly
Interact with Firm’s institutional sales force and investor clients
Respond to client and internal inquiries regarding research findings and directives
Qualification
Required
Bachelor's degree required
Ability to search, understand and interpret scientific and medical publications and presentations
Preferred
MD, PhD., or other advanced life sciences degree
1-3 years of professional industry experience in industry, consulting, or similar
Exceptional analytical, verbal, and written communication skills
Analytical mindset, intellectual curiosity, aptitude for math/statistics
Company
Guggenheim Securities
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners. It is a sub-organization of Guggenheim Partners.
1001-5000 employees
H1B Sponsorship
Guggenheim Securities has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (10)
2023 (10)
2022 (13)
2021 (18)
2020 (13)
Funding
Current Stage
Late StageLeadership Team
Mark Van Lith
Chief Executive Officer
Recent News
2026-01-07
2025-12-17
Company data provided by crunchbase